All Topics Brain Cancer Breast Cancer Gastrointestinal Cancer Genitourinary Cancers Gynecologic Oncology Head & Neck Cancers Hematologic Oncology Lung Cancer Melanoma & Skin Cancer Sarcomas/TGCT
Browse by Series:
All Peer Exchange A Rapid Shift in Treatment for Chronic Lymphocytic Leukemia The Evolving Role of CAR T Cell Therapy in Hematological Malignancies Extensive Stage Small-Cell Lung Cancer Prostate Cancer: Evolving Treatment Approaches Advanced Ovarian Cancer: New Perspectives on Systemic Therapy Multimodality Management of Advanced Liver Cancer Precision Medicine: A New Frontier for Advanced Cholangiocarcinoma Non-Small-Cell Lung Cancer: Perspectives on Key Data Advances in the Treatment of Prostate Cancer Recent Developments in Management of Gynecologic Cancers Contemporary Management of Metastatic Renal Cell Carcinoma Updates in the Management of Follicular Lymphoma Updates in Targeted Therapies for B-Cell Malignancies Multidisciplinary Treatment Strategies for Hepatocellular Carcinoma Advances in the Treatment of Pancreatic Cancer Precision Medicine in Acute Myeloid Leukemia Treatment Precision Medicine in NSCLC: Ramifications of Recent Data Advanced Gastric or Gastro-Esophageal Cancers Expert Perspectives on the Treatment of Melanoma Evolving Concepts in Treatment for Advanced Breast Cancer Personalized Strategies for Advanced Colorectal Cancers Management of Myeloproliferative Neoplasms: A Focus on Polycythemia Vera and Myelofibrosis Malignant Melanoma: Contemporary Management Navigating Evolving Therapy Choice in Multiple Myeloma Recent Updates in Use of Immunotherapy for Lung Cancer Optimizing Therapy for Hairy Cell Leukemia Shifting Paradigms in Ovarian Cancer TRK Inhibitors: Precision Medicine in Oncology Advanced Breast Cancer: Key Updates in Clinical Care Practical Strategies for Treatment of Clear-Cell Renal Cell Carcinoma Emerging Treatment Paradigms for Advanced Lung Cancer Navigating New Treatment Options for Advanced HCC Evolving Strategies for Advanced Colon and Rectal Cancers Adult Immune Thrombocytopenia Purpura Revolution of Therapy in Acute Lymphoblastic Leukemia Follicular Lymphoma: Evolving Treatment Landscape Refining Systemic Therapy for Multiple Myeloma Evolving Treatment Patterns in Breast Cancer Practical Implications for New Data in Lung Cancer Systemic Therapy Acute Myeloid Leukemia: The Path to Personalized Medicine The Evolution of Chimeric Antigen Receptor T Cell Therapy Global Expert Perspectives on Treatment Strategies in Neuroendocrine Tumors Optimizing Systemic Therapy for Chronic Lymphocytic Leukemia Advances and Best Practices in the Utilization of Novel Agents in Metastatic Breast Cancer Unmet Needs in HR-Positive Metastatic Breast Cancer Treatment Advances for Advanced Melanoma Emerging Treatment Patterns for Hepatocellular Carcinoma Advanced Ovarian Cancer: Optimizing Therapy Based on Current Data EU Perspective: Evolving Topics in Prostate Cancer Optimal Treatment for Advanced Colon and Rectal Cancers Exciting Advances in the Treatment of Advanced NSCLC Key Updates and Practice-Changing Data for Advanced NSCLC Future Directions for Precision Medicine in Advanced NSCLC Clinical Perspectives on New Data in Advanced NSCLC Management of Chronic Myeloid Leukemia An Evolving Treatment Paradigm for Hepatocellular Carcinoma Evolving Strategies for Advanced Colon and Rectal Cancer Global Perspective on Treatment of Hepatocellular Carcinoma Therapeutic Strategies in Advanced Ovarian Cancer New Treatment Paradigms for Advanced Melanoma Precision Medicine in Advanced Non-Small Cell Lung Cancer Advanced Pancreatic Cancer: The Road to Personalized Care Management of Follicular Lymphoma Global Perspectives on Sequencing in Gastroesophageal Cancers Next-Generation Regimens for Multiple Myeloma Expanding Therapeutic Options for Breast Cancer Systemic Management of Advanced Soft Tissue Sarcoma Evolving Treatment Paradigms for Renal Cell Carcinoma Management of Myeloproliferative Neoplasms The New Frontier in NSCLC: Immuno-Oncology Combinations Advanced Ovarian Cancer: Practical Essentials Optimizing Treatment in Polycythemia Vera Redefining Advanced Prostate Cancer with Novel Imaging Therapeutic Sequencing Strategies for Advanced Kidney Cancer Practice Changing Trials in Advanced Non-Small Cell Lung Cancer Colorectal Cancer: Individualizing Treatment, Improving Outcomes Expanding the Armamentarium in Metastatic Liver Cancer Perspectives on Systemic Therapy for Breast Cancer Emerging Concepts in Treating Triple-Negative Breast Cancer Practical Perspectives on Acute Lymphocytic Leukemia Multiple Myeloma: Emerging Concepts in Management The Era of Targeted Therapy for Acute Myeloid Leukemia Hematopoietic Stem Cell Transplant: Infection Control Considerations in the Management of Adult ITP Refining Therapy for Chronic Lymphocytic Leukemia CAR-T Cell Therapy Use in B-Cell Malignancies Refining Therapeutic Strategies for Follicular Lymphoma Personalized Therapy Approaches for Mantle Cell Lymphoma Metastatic Prostate Cancer: A Practical Review of Therapy Global Perspectives on Advanced Breast Cancer Management Viewpoints on Pancreatic Ductal Adenocarcinoma Advances in Systemic Therapy for Melanoma Global Outlook on Advanced Nonsquamous NSCLC Immuno-Oncology in Advanced Lung Cancer The Long Game: Management Strategies in Kidney Cancer Advanced Head and Neck Cancers-Looking Forward Refining the Management of Advanced Melanoma Moving the Needle in HCC: International Experts Weigh In Novel Concepts in the Management of Multiple Myeloma Sequencing Decisions in Gastroesophageal Cancers Management of Chemotherapy-Induced Nausea and Vomiting (CINV) Advanced Ovarian Cancer: Recent Advances and Unmet Needs Personalizing Therapy for Advanced Prostate Cancer The Biology of Extending Survival in Advanced CRC Nuances in Treating Advanced Lung Adenocarcinoma Questions and Controversies in Treating Breast Cancer The New Frontier: Treating Advanced Kidney Cancer Immunotherapy Use in Advanced Urothelial Carcinoma Breast Cancer: A Continuum of Care Update on Metastatic Squamous Non-Small Cell Lung Cancer Novel Therapeutic Approaches in Metastatic Lung Adenocarcinoma The Evolution of Sequencing Strategies in Pancreatic Cancer Optimizing Treatment Selection in Liver Cancer The Divide and Conquer of Advanced Colorectal Cancer Expert Views on Therapy for Ovarian, Fallopian, and Peritoneal Cancers Treatment of Multiple Myeloma in 2017 and Beyond Optimizing Infection Control to Improve Outcomes of Allogeneic Stem Cell Transplant Evolving Treatment Paradigms for B-Cell Non-Hodgkin Lymphoma Myelodysplastic Syndrome: Managing Risk and Complications Moving Toward Precision Medicine in Adult Acute Myeloid Leukemia Practical Management of Advanced Melanoma: A Case-Based Discussion Key Issues Surrounding the Treatment of Prostate Cancer Precision Medicine in Breast Cancer A New Era for Treatment of Advanced Head and Neck Cancers Treating Advanced Gastroesophageal Cancers Global Perspectives on the Management of Malignant Melanoma Therapeutic Options in Recurrent Soft Tissue Sarcoma Management of Chemotherapy-Induced Nausea & Vomiting Immunotherapy Use in Advanced Lymphoid Malignancies Latest Advances in Lung Adenocarcinoma State of the Art: Treatment of Advanced Melanoma Optimizing Systemic Therapy in Advanced Colorectal Cancer Immunotherapy Use in Advanced Solid Tumors Expert Perspectives on the Latest Advancements in Breast Cancer Sequencing Therapies in Advanced Renal Cell Carcinoma New Therapeutic Approaches for Multiple Myeloma Clinical Challenges in Genitourinary Cancers Myelodysplastic Syndromes: Translating Genetics to Clinical Practice Anti-Angiogenic Therapy in Lung and GI Cancers Update on Treatment of Advanced Liver Cancer Treating Advanced Differentiated Thyroid Cancer Metastatic Adenocarcinoma of the Lung Management of Myelodysplastic Syndromes: A Focus on Supportive Care Treating Advanced Squamous Non-Small Cell Lung Cancer Neuroendocrine Tumors: An Evidence-Based Discussion Progress and Promise in Advanced Pancreatic Cancer The Role of Anti-Angiogenic Therapy in Lung Cancer Therapeutic Strategies in Metastatic Colorectal Cancer Treating Advanced Renal Cell Carcinoma Update on Advanced Breast Cancer Treatment Perspectives on Metastatic Kidney Cancer New Agents in Chronic Lymphocytic Leukemia: A Practical Guide Expert Perspectives on the Management of Chronic Myeloid Leukemia New Treatment Paradigms in Multiple Myeloma Expert Perspectives: Management of Acute Myeloid Leukemia Metastatic Melanoma: The New Millennium Treatment of Advanced Prostate Cancer: Expert Evaluations of Recent Studies Multidisciplinary Treatment of Advanced Soft Tissue Sarcomas Lung Cancer Treatment - 2015 Update Multidisciplinary Treatment of Pancreatic Neuroendocrine Tumors Practice Update on Advanced Kidney Cancer Global Perspectives on Treatment of Metastatic Colorectal Cancer Colorectal Cancer: A Practical Review Emerging Concepts-Advanced Ovarian, Fallopian, Peritoneal, and Cervical Cancers Emerging Concepts in the Treatment of Multiple Myeloma Update on Use of Immunotherapy in Hematologic Malignancies 2015 Update - Latest Advances in Breast Cancer Treatment Integrating Prostate Cancer Trial Findings Into Practice: A Case-Based Discussion Taking a Multidisciplinary Approach to Hepatocellular Carcinoma Reshaping Oncology Care Delivery and Payments Refining Approaches to Reach Treatment Goals in mRCC Aiming for Precision Medicine in NSCLC Exploring Current Treatment Practices in NSCLC Expert Perspectives in Metastatic Breast Cancer Updates on the Treatment of Malignant Melanoma Biomarker Tests and Emerging Therapies in Prostate Cancer 2015 Update on Colorectal Cancer Changing Treatment for CLL and Non-Hodgkin's Lymphoma Management and Treatment of Chronic Myeloid Leukemia Treatment of Multiple Myeloma Treatment and management of Acute Leukemia Integrating New Services into Urology Practices Updates in Ovarian and Cervical Cancers Treating Advanced Breast Cancer in Community Settings Optimizing the Treatment of mCRC Antibody-Based Cancer Immunotherapy Unmet Needs in the Treatment of Lung Cancer Evolving Therapeutic Landscape in Thyroid Cancer Therapeutic Advances and Key Case Studies in RCC Practical Considerations in Metastatic Melanoma Therapeutic Advances and Unmet Challenges in mCRPC Management of Breakthrough Pain in Cancer Patients Minimizing Toxicity While Maintaining Efficacy in RCC Lymphoid Malignancy Treatment Considerations Effective Sequencing of Treatments for pNETs Treatment Considerations in Refractory CRC Current Therapeutic Advances in Metastatic Pancreatic Cancer Improving Clinical Outcomes in NSCLC Changing Therapeutic Landscape in ALL, CLL, and NHL Practical Considerations in Breast Cancer Recent Advances in MDS and CML Managing Bone Health in Cancer Patients Updates in the Management of CRPC Treatment of Metastatic Colorectal Cancer Current and Emerging Therapies in NSCLC Medullary Thyroid Cancer: Advances and Challenges Prostate Cancer Case Studies Clinical Developments in Renal Cell Carcinoma Metastatic Breast Cancer Treatment Challenges Management of Hodgkin Lymphoma Advances in Colorectal Cancer Management of Neuroendocrine Tumors Advances and Issues in NSCLC Effective Management of Prostate Cancer Managing Metastatic Breast Cancer Advances and Issues of Early Breast Cancer Prostate Cancer: Practice Management Urologists in Cancer Care: Focus on Prostate Cancer Small Cell Lung Cancer: Interpreting Data From IMpower133 VIDEO
Charles Rudin, MD, PhD: The IMpower133 trial was a randomized phase III trial comparing a standard of care of carboplatin and etoposide versus the same chemotherapy regimen with the addition of the anti–PD-L1 [anti–programmed death-ligand 1] inhibitor atezolizumab. It was a 1:1 randomization and included about 400 patients and showed an improvement in median overall survival from about 10½ months in the control arm to about 12½ months on the investigational arm. We would have liked to see a more dramatic change than that, but the median shift was only about 2 months. I think what will be really interesting in looking at this trial going forward is what the long-term outcome is on the investigational arm. We know that some patients treated with immunotherapy do derive long-term benefit with small cell lung cancer. There may be patients who are in fact long-term survivors on that trial. It’s too early to know. We’ve seen only early data from that study to date. We’ll be very eager to see updates in the years going forward.
Currently the uptake of anti–PD-L1 therapy has been primarily in the United States, based on an early approval there. There has been recent adoption of this regimen in Germany as well, and I think this is slowly becoming a change that will happen in the rest of the world as well. For many countries, this is not yet an approved therapy.
Transcript Edited for Clarity